Evidence map›Paper›PMID 36205005›Full record

ArticleInternational journal of geriatric psychiatry2022

The relationship between depressive symptoms and subtypes of mild cognitive impairment in post-menopausal women: Results from the Women's Health Initiative Memory Study.

Laura E Korthauer, Joseph S Goveas, Stephen R Rapp, Mark A Espeland, Sally A Shumaker, Katelyn R Garcia, Rebecca C Rossom, Lorena Garcia, Hilary A Tindle, Elena Salmoirago-Blotcher and 6 more

Open access · greenAbstract read
In one paragraph

Article in International journal of geriatric psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 1 country.

Laura E KorthauerDepartment of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Joseph S GoveasDepartment of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Stephen R RappDepartment of Psychiatry and Behavioral Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Mark A EspelandDepartment of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Sally A ShumakerDepartment of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Katelyn R GarciaDepartment of Biostatistics and Data Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Rebecca C RossomHealthPartners Institute, Minneapolis, Minnesota, USA.
Lorena GarciaDepartment of Public Health Sciences, University of California-Davis, Davis, California, USA.
Hilary A TindleDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Elena Salmoirago-BlotcherDepartment of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Sylvia Wassertheil-SmollerDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, New York, New York, USA.
Oleg ZaslavskyDepartment of Biobehavioral Nursing and Health Informatics, University of Washington, Seattle, Washington, USA.
Barbara CochraneDepartment of Child, Family, and Population Health Nursing, University of Washington, Seattle, Washington, USA.
Kaycee M SinkGenentech Inc, South San Francisco, Carolina, USA.
Kamal MasakiDepartment of Geriatric Medicine, University of Hawaii, Honolulu, Hawaii, USA.
Ira DriscollDepartment of Psychology, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.ORCID 0000-0002-1737-3343
Wake Forest University · USBrown University · USUniversity of Washington · USAcentech (United States) · USAlbert Einstein College of Medicine · USHealthPartners · USMedical College of Wisconsin · USUniversity of California, Davis · USUniversity of Hawaii System · USUniversity of Pittsburgh · USUniversity of Wisconsin–Milwaukee · US

Funding

Wake Forest University School of Medicine Alzheimer's Disease Research CenterP30AG072947 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SHANNON L RISACHER · 2021 to 2026
$24.3M
WOMENS HEALTH INITIATIVE-N01WH22110N01WH022110 · WH · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSS, PRENTICE · 1992 to 2006
$1.2M
NIA NIH HHS HHSN271201100004CNIA NIH HHS P30 AG072947WHI NIH HHS N01 WH022110
6 · The paper itself

Abstract

backgroundDepressive symptoms are associated with age-related cognitive impairment, but the relative risk of specific subtypes of mild cognitive impairment (MCI) conferred by depressive symptoms is unclear. The purpose of this exploratory study was to determine the longitudinal association between baseline depressive symptoms and incident cases of MCI subtypes (amnestic vs. non-amnestic) and probable dementia (PD) (Alzheimer's disease, vascular, mixed) among postmenopausal women.

methodsDepressive symptoms were assessed at study baseline using an 8-item Burnam algorithm in 7043 postmenopausal women who participated in the Women's Health Initiative Memory Study (WHIMS) and the WHIMS-Epidemiology of Cognitive Health Outcomes (WHIMS-ECHO) extension study. During the median 9.4-year follow-up interval, the presence of MCI and PD was classified by a central adjudication committee. Classification of participants by MCI subtype (amnestic single and multi-domain, non-amnestic single and multi-domain) was done algorithmically based on established criteria using data from annual cognitive testing.

resultsAt baseline, 557 women (7.9%) had clinically significant depressive symptoms based on Burnam algorithm cut-point of 0.06. Depressive symptoms at baseline were associated with an increased risk of incident amnestic MCI (hazard ratio [HR] = 1.91, 95% confidence interval [CI] 1.32-2.78, p < 0.0001), but not non-amnestic MCI (HR = 1.39, 95% CI 0.91-2.14, p = 0.13) after controlling for demographic factors. This relationship between depressive symptoms and amnestic MCI remained consistent after controlling for lifestyle variables, cardiovascular risk factors, antidepressant use, and history of hormone therapy. There were no significant associations between depressive symptoms and incidence of PD.

conclusionDepressive symptoms at baseline among postmenopausal older women are associated with higher incidence of amnestic MCI, suggesting that they may be an independent risk factor or part of the early prodrome of dementia.

Indexed as

Cognitive DysfunctionDementiaAgedAntidepressive AgentsDepressionFemaleHormonesHumansNeuropsychological TestsPostmenopauseRisk FactorsWomen's HealthAntidepressive AgentsHormonesAlzheimer's diseasedementiadepressionMCI subtypesmild cognitive impairment

Identifiers

PMID36205005
PMCPMC9616073
OpenAlexW4300819003

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.